Literature DB >> 18554702

Anaphylaxis to dyes during the perioperative period: reports of 14 clinical cases.

Paul Michel Mertes1, Jean Marc Malinovsky, Claudie Mouton-Faivre, Marie Caroline Bonnet-Boyer, Abdelhaouad Benhaijoub, François Lavaud, Jocelyne Valfrey, James O'Brien, Philippe Pirat, Laurent Lalourcey, Pascal Demoly.   

Abstract

BACKGROUND: Vital dyes are widely used for lymphatic mapping and sentinel lymph node biopsy in patients with malignant tumors, and reports of anaphylactic reactions are becoming more frequent.
OBJECTIVE: Our aims were to describe specific clinical features of hypersensitivity reactions to Patent Blue (Guerbet, Roissy, France), results of the allergy workup, and their consequences for patient management.
METHODS: We report a series of 14 clinical cases of dye-induced anaphylaxis recorded between 2004 and 2006 in 4 member centers of a network of French allergoanesthesia outpatient clinics.
RESULTS: Reactions appeared to be relatively severe (6/14 grade III reactions). An average 30 +/- 6-minute delay was observed between dye injection and symptom onset. In 9 (65%) patients reactions were sustained for several hours, requiring prolonged continuous epinephrine infusion and transfer to an intensive care unit. Prick test results were positive in 8 patients. In 5 patients prick test results were negative, whereas intradermal test results were positive.
CONCLUSION: Anesthesiologists and allergologists must be aware of this specific risk and of the clinical characteristics of these reactions, which are usually delayed and long lasting.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18554702     DOI: 10.1016/j.jaci.2008.04.040

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  12 in total

1.  Anaphylaxis to patent blue dye in a 17-year-old boy.

Authors:  Mélanie Leung; Christine McCusker; Moshe Ben-Shoshan
Journal:  BMJ Case Rep       Date:  2019-01-22

2.  Anaphylactic shock perioperative to patent blue dye.

Authors:  João Pedro Azevedo; Marta Alves; Carmelita Ribeiro; Ana Todo Bom
Journal:  BMJ Case Rep       Date:  2018-05-07

3.  [Patent blue V : inert dye or potent allergen].

Authors:  V Rogler; C Röhm; J Reutershan
Journal:  Anaesthesist       Date:  2010-05       Impact factor: 1.041

Review 4.  Anaphylaxis to drug excipients.

Authors:  Wolfgang Pfützner
Journal:  Allergo J Int       Date:  2022-05-31

5.  Multi-centre retrospective analysis of anaphylaxis during general anaesthesia in the United Kingdom: aetiology and diagnostic performance of acute serum tryptase.

Authors:  M T Krishna; M York; T Chin; G Gnanakumaran; J Heslegrave; C Derbridge; A Huissoon; L Diwakar; E Eren; R J Crossman; N Khan; A P Williams
Journal:  Clin Exp Immunol       Date:  2014-11       Impact factor: 4.330

6.  Safety and efficacy of computed tomography-guided dye localization using patent blue V for single lung nodule for video-assisted thoracoscopic surgery: a retrospective study.

Authors:  Jing-Ru Chen; Yao-Hui Tseng; Mong-Wei Lin; Hsin-Ming Chen; Yi-Chang Chen; Mei-Chi Chen; Yee-Fan Lee; Jin-Shing Chen; Yeun-Chung Chang
Journal:  Ann Transl Med       Date:  2019-01

7.  Anaphylaxis to Patent Blue V: a case series.

Authors:  Ania L Manson; Rohit Juneja; Robert Self; Paul Farquhar-Smith; Fiona Macneill; Suranjith L Seneviratne
Journal:  Asia Pac Allergy       Date:  2012-01-31

Review 8.  Epidemiology, Mechanisms, and Diagnosis of Drug-Induced Anaphylaxis.

Authors:  Maria Isabel Montañez; Cristobalina Mayorga; Gador Bogas; Esther Barrionuevo; Ruben Fernandez-Santamaria; Angela Martin-Serrano; Jose Julio Laguna; Maria José Torres; Tahia Diana Fernandez; Inmaculada Doña
Journal:  Front Immunol       Date:  2017-05-29       Impact factor: 7.561

Review 9.  Peri-Operative Anaphylaxis-An Investigational Challenge.

Authors:  Siraj A Misbah; Mamidipudi Thirumala Krishna
Journal:  Front Immunol       Date:  2019-05-29       Impact factor: 7.561

Review 10.  Perioperative Anaphylaxis: Evaluation and Management.

Authors:  Deepti Vellaichamy Manian; Gerald W Volcheck
Journal:  Clin Rev Allergy Immunol       Date:  2021-07-10       Impact factor: 8.667

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.